Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Bernstein

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Molecular Cell|June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant MelanomaChiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Cell Stem Cell|January 10, 2012
MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiationAna O'Loghlen, Ana M Muñoz-Cabello, Alexandre Gaspar-Maia, et al.
The Journal of Clinical Investigation|August 2, 2021
Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotypeLaura Lecce, Yang Xu, Bhargavi V'Gangula, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
JCI Insight|May 5, 2017
Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationBrateil Badal, Alexander Solovyov, Serena Di Cecilia, et al.
Communications Biology|February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogrammingWazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Nature Communications|October 17, 2022
A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinomaRoyce W Zhou, Jia Xu, Tiphaine C Martin, et al.
Nature Communications|April 6, 2023
Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinomaRoyce W Zhou, Jia Xu, Tiphaine C Martin, et al.
JCI Insight|July 27, 2018
The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanomaOrsi Giricz, Yongkai Mo, Kimberly B Dahlman, et al.
EMBO Molecular Medicine|August 20, 2024
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Molecular Cell|June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant MelanomaChiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Cell Stem Cell|January 10, 2012
MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiationAna O'Loghlen, Ana M Muñoz-Cabello, Alexandre Gaspar-Maia, et al.
The Journal of Clinical Investigation|August 2, 2021
Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotypeLaura Lecce, Yang Xu, Bhargavi V'Gangula, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
JCI Insight|May 5, 2017
Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationBrateil Badal, Alexander Solovyov, Serena Di Cecilia, et al.
Communications Biology|February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogrammingWazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Nature Communications|October 17, 2022
A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinomaRoyce W Zhou, Jia Xu, Tiphaine C Martin, et al.
Nature Communications|April 6, 2023
Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinomaRoyce W Zhou, Jia Xu, Tiphaine C Martin, et al.
JCI Insight|July 27, 2018
The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanomaOrsi Giricz, Yongkai Mo, Kimberly B Dahlman, et al.
EMBO Molecular Medicine|August 20, 2024
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibitionSarah Proteau, Imène Krossa, Chrystel Husser, et al.
Pageof 9